Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 713,000 | 233,000 | 251,100 | 262,900 | 340,800 |
| Marketable Securities | 767,400 | 843,100 | 780,500 | 726,400 | 370,500 |
| Receivables | 686,800 | 479,100 | 439,300 | 350,000 | 185,500 |
| Inventories | 69,000 | 57,400 | 38,300 | 35,100 | 30,500 |
| Other current assets | 115,800 | 63,600 | 97,800 | 79,100 | 45,500 |
| TOTAL | $2,522,700 | $1,724,700 | $1,607,000 | $1,453,500 | $972,800 |
| Non-Current Assets | |||||
| PPE Net | 89,800 | 82,600 | 70,800 | 58,600 | 58,600 |
| Investments And Advances | 1,183,800 | 864,300 | 849,400 | 401,500 | 624,400 |
| Intangibles | 0 | 0 | 35,500 | 37,200 | 0 |
| Other Non-Current Assets | 835,200 | 1,047,100 | 688,700 | 417,900 | 416,700 |
| TOTAL | $2,108,800 | $1,994,000 | $1,644,400 | $915,200 | $1,099,700 |
| Total Assets | $4,631,500 | $3,718,700 | $3,251,400 | $2,368,700 | $2,072,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 674,300 | 461,600 | 448,800 | 347,600 | 225,800 |
| Other current liabilities | 69,100 | 46,100 | 35,900 | 20,700 | 20,000 |
| TOTAL | $743,400 | $507,700 | $654,800 | $537,700 | $245,800 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 335,100 |
| Other Non-Current Liabilities | 635,000 | 621,300 | 364,600 | 123,200 | 117,600 |
| TOTAL | $635,000 | $621,300 | $364,600 | $123,200 | $452,700 |
| Total Liabilities | $1,378,400 | $1,129,000 | $1,019,400 | $660,900 | $698,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 100,364 | 99,704 | 99,507 | 96,588 | 95,243 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 447,700 | 29,200 | -157,100 | -406,800 | -635,800 |
| Other shareholders' equity | 13,100 | 5,800 | 7,000 | -7,900 | -1,700 |
| TOTAL | $3,253,100 | $2,589,700 | $2,232,000 | $1,707,800 | $1,374,000 |
| Total Liabilities And Equity | $4,631,500 | $3,718,700 | $3,251,400 | $2,368,700 | $2,072,500 |